Company Overview

Update
Status:
Acquired by Bio-Rad Laboratories
Founded:
2009
Founders:
John Boyce
Headquarters:
Cambridge, MA
Funding:
$22.50M
Categories:
Biotechnology

GnuBIO is a leading developer of scalable DNA sequencing technology for the diagnostic and applied markets.

Description

Update

GnuBIO is a leading developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIO’s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.

Current Team (5)

Update

Funding Rounds (4) - $22.50M

Update

Offices/Locations (1)

Update
  • Office

    1 Kendall Square

    Building 1400, Suite 14201

    Cambridge, MA 02139

    USA

Images (1)

Update
  • 925a5ceac605c621b676e403ac6005cb